Current Trends in Diabetic Foot Disease
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Endocrinology and Metabolism Research".
Deadline for manuscript submissions: 31 July 2025 | Viewed by 135
Special Issue Editor
Special Issue Information
Dear Colleagues,
Diabetic foot ulcer (DFU) is one of the most refractory complications in diabetes mellitus, resulting in enormous economic, social, and public health burdens. Normal wound healing includes four continuous phases, that is, hemostasis, inflammation, proliferation, and remodeling. Diabetes causes delayed wound healing via multifarious biological mechanisms, which affect the transition of the organized phases.
Conventional therapeutic strategies of DFU consist of glucose and infection control, debridement, wound off-loading, dressings, and revascularization. However, the healing duration of DFUs ranges from 3 months to more than 12 months after these current treatments. It is of significant interest to develop more effective and economic treatments for DFUs.
This Special Issue welcomes the submission of original research articles, clinical trials, case report, reviews, short communications, and commentaries on the new therapeutic strategies targeting these mechanisms, such as bioengineered skin substitutes, exogenous growth factors, drugs regulating unbalanced inflammatory responses, and the transplantation of stem/progenitor cells.
Prof. Dr. Xuefeng Yu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes
- diabetic foot
- endocrinology
- metabolic disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
